Overview
Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness.
Dr. Gartrell is rated as an Experienced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.
His clinical research consists of co-authoring 63 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- PPO
- MEDICARE-MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
111 East 210th Street, Bronx, NY 10461
1695 Eastchester Road, Bronx, NY 10461
1575 Blondell Avenue, Bronx, NY 10461
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
17 Clinical Trials
New York University
Rajeev Balmiki is an Oncologist and a Hematologist in New York, New York. Dr. Balmiki is rated as an Advanced provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Bone Marrow Aspiration.
HMH - John Theurer Cancer Center - Hackensack
Jamie Koprivnikar is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Koprivnikar is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Endoscopy.
Titan Health Partners LLC
Steven Young is an Oncologist and a Hematologist Oncology provider in East Brunswick, New Jersey. Dr. Young is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. His top areas of expertise are Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Familial Colorectal Cancer. Dr. Young is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaDr. Gartrell isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Gartrell isDistinguished. Learn about Bladder Cancer.
- Clear Cell SarcomaDr. Gartrell isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Gartrell isDistinguished. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Gartrell isDistinguished. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Gartrell isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Advanced
- Chromophobe Renal Cell CarcinomaDr. Gartrell isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Familial Wilms Tumor 2Dr. Gartrell isAdvanced. Learn about Familial Wilms Tumor 2.
- Lung CancerDr. Gartrell isAdvanced. Learn about Lung Cancer.
- Muscle Invasive Bladder CancerDr. Gartrell isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Gartrell isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Pleuropulmonary BlastomaDr. Gartrell isAdvanced. Learn about Pleuropulmonary Blastoma.
- Experienced
- Adrenal CancerDr. Gartrell isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Gartrell isExperienced. Learn about Adrenocortical Carcinoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Gartrell isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Ampullary CancerDr. Gartrell isExperienced. Learn about Ampullary Cancer.
- Bone TumorDr. Gartrell isExperienced. Learn about Bone Tumor.
- ChoriocarcinomaDr. Gartrell isExperienced. Learn about Choriocarcinoma.